Experience with micronized progesterone in obstetric practice
- Authors: Khodzhaeva Z.S.1, Klimenchenko N.I.1, Muminova K.T.1, Gorina K.A.1, Frankevich V.E.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 7 (2021)
- Pages: 174-178
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249446
- DOI: https://doi.org/10.18565/aig.2021.7.174-178
- ID: 249446
Cite item
Abstract
Full Text
About the authors
Zulfiya S. Khodzhaeva
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: zkhodjaeva@mail.ru
MD, PhD, Professor, Deputy Director of Obstetrics Institute
Nataliya I. Klimenchenko
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: n_klimenchenko@oparina4.ru
PhD, Senior Researcher of High Risk Pregnancy Department
Kamilla T. Muminova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: k_muminova@oparina4.ru
PhD, Researcher of High Risk Pregnancy Department
Kseniya A. Gorina
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: k_gorina@oparina4.ru
PhD, Researcher of High Risk Pregnancy Department
Vladimir E. Frankevich
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: v_frankevich@oparina4.ru
PhD, Head of the Department of Systems Biology in Reproduction
References
- Romero R., Dey S.K., Fisher S.J. Preterm labor: One syndrome, many causes. Science. 2014; 345(6198): 760-5. https://dx.doi.org?https://dx.doi.org/10.1126/ science.1251816.
- Romero R. Prenatal medicine: The child is the father of the man. J. Matern. Fetal Neonatal Med. 2009; 22(8): 636-9. https://dx.doi.org/10.1080/14767050902784171.
- Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil. Steril. 2012; 98(5): 1103-11. https://dx.doi.org/10.1016/j.fertnstert.2012.06.048.
- Haas D.M., Hathaway T.J., Ramsey P.S. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst. Rev. 2019; (11): CD003511. https://dx.doi.org/10.1002/14651858. CD003511.pub5.
- Coomarasamy A., Harb H.M., Devall A.J., Cheed V., Roberts T.E., Goranitis I. et al. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT. Health Technol. Assess. 2020; 24(33): 1-70. https://dx.doi.org/110.3310/hta24330.
- Мальцева Л.И., Никогосян Д.М. Эффективность микронизированного прогестерона для профилактики невынашивания беременности. Гинекология. 2015; 17(2): 56-9.
- Радзинский В.Е., Ордиянц И.М., Побединская О.С., Зыков Е.В. Прогестерон и репродуктивные потери. Акушерство и гинекология. 2017; 8: 109-14. https://dx.doi.org/10.18565/aig.2017.8.109-114.
- Гончарова С.В., Башмакова Н.В. Потеря беременности: патогенетическая терапия и ее исходы у женщин группы высокого риска. Вопросы гинекологии, акушерства и перинатологии. 2014; 13(3): 19-26.
- Bulletti C., de Ziegler D., Flamigni C., Giacomucci E., Polli V., Bolelli G., Franceschetti F. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum. Reprod. 1997; 12(5): 1073-9. https://dx.doi.org/10.1093/humrep/12.5.1073.
- Joshi J.T. A review on micronization techniques. J. Pharm. Sci. Technol. 2011; 3(7): 651-81.
- ESHRE Guideline on Ovarian Stimulation for IVF/ICSI. 2017.
- Coomarasamy A., Williams H., Truchanowicz E., Seed P.T., Small R., Quenby S., Gupta P. et al. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation, Health Technol. Assess. 2016; 20(41): 1-92. https://dx.doi.org/10.3310/hta20410.
- Coomarasamy A., Devall A.J., Brosens J.J., Quenby S., Stephenson M.D., Sierra S. et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am. J. Obstet. Gynecol. 2020; 223(2): 16776. https://dx.doi.org/10.1016/j.ajog.2019.12.006.
- Ogwulu C.B.O., Goranitis I., Devall A.J., Cheed V., Gallos I.D., Middleton L.J. et al. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial. BJOG. 2020; 127(6): 757-67. https://dx.doi.org/10.1111/1471-0528.16068.
- McNamara H.C., Wood R., Chalmers J., Marlow N., Norrie J., MacLennan G. et al. STOPPIT Baby Follow-up Study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome. PLoS One. 2015; 10(4): e0122341. https://dx.doi.org/10.1371/journal.pone.0122341.
- Devall A.J., Papadopoulou A., Podesek M., Haas D.M., Price M.J., Coomarasamy A., Gallos I.D. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database Syst. Rev. 2021; (4): CD013792. https://dx.doi.org/10.1002/14651858. CD013792.pub2.